Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A) Latest Advances

Letter: Fluoxetine for Behavioral Problems in an 8-Year-Old with Mucopolysaccharidosis IIIA.

Journal: Journal of child and adolescent psychopharmacology

Published: February 09, 2026

Sanfilippo syndrome type A with acute metabolic acidosis: a case report of the first documented SGSH c.571G > A homozygous mutation.

Journal: BMC pediatrics

Published: December 01, 2025

The first case of sick sinus syndrome with an adult Sanfilippo A syndrome: a case report with review of literature.

Journal: BMC neurology

Published: May 01, 2025

Clinical, biochemical, and molecular characteristics of Sanfilippo a syndrome (MPS IIIA) in a cohort of Egyptian patients.

Journal: Orphanet journal of rare diseases

Published: March 14, 2025

Synthesis of the endogenous non-reducing end heparan sulfate disaccharide for newborn screening and diagnosis of Mucopolysaccharidosis type IIIA.

Journal: Carbohydrate research

Published: March 03, 2025

Survey of Patients With Sanfilippo Type a (MPS IIIA) Disease Diagnosed by the MPS Brazil Network.

Journal: American journal of medical genetics. Part A

Published: December 25, 2024

Acute transient psychotic episode as presenting sign of Mucopolysaccharidosis III A (Sanfilippo Syndrome type A) in an adolescent patient.

Journal: European child & adolescent psychiatry

Published: November 20, 2024

Human induced pluripotent stem cell line (PNUSCRi006-A) derived from a patient with Sanfilippo syndrome type A exhibiting a mutation in SGSH gene.

Journal: Stem cell research

Published: October 23, 2024

Mucopolysaccharidoses types I and IIIA: Diagnosis and identification of novel polymorphisms associated with common mutations in Moroccan patients.

Journal: Molecular genetics and metabolism reports

Published: June 07, 2024

Initiation of fluoxetine in a pediatric patient with Mucopolysaccharidosis IIIA: Early observations.

Journal: Molecular genetics and metabolism reports

Published: January 22, 2024

Ability change across multiple domains in mucopolysaccharidosis (Sanfilippo syndrome) type IIIA.

Journal: Molecular genetics and metabolism

Published: October 01, 2023

Late-onset mucopolysaccharidosis type IIIA mimicking Usher syndrome.

Journal: American journal of medical genetics. Part A

Published: September 27, 2023

Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A) Latest Advances

Find the Latest Research About Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A)

Letter: Fluoxetine for Behavioral Problems in an 8-Year-Old with Mucopolysaccharidosis IIIA.

Letter: Fluoxetine for Behavioral Problems in an 8-Year-Old with Mucopolysaccharidosis IIIA.

Sanfilippo syndrome type A with acute metabolic acidosis: a case report of the first documented SGSH c.571G > A homozygous mutation.

Sanfilippo syndrome type A with acute metabolic acidosis: a case report of the first documented SGSH c.571G > A homozygous mutation.

The first case of sick sinus syndrome with an adult Sanfilippo A syndrome: a case report with review of literature.

The first case of sick sinus syndrome with an adult Sanfilippo A syndrome: a case report with review of literature.

Clinical, biochemical, and molecular characteristics of Sanfilippo a syndrome (MPS IIIA) in a cohort of Egyptian patients.

Clinical, biochemical, and molecular characteristics of Sanfilippo a syndrome (MPS IIIA) in a cohort of Egyptian patients.

Synthesis of the endogenous non-reducing end heparan sulfate disaccharide for newborn screening and diagnosis of Mucopolysaccharidosis type IIIA.

Synthesis of the endogenous non-reducing end heparan sulfate disaccharide for newborn screening and diagnosis of Mucopolysaccharidosis type IIIA.

Survey of Patients With Sanfilippo Type a (MPS IIIA) Disease Diagnosed by the MPS Brazil Network.

Survey of Patients With Sanfilippo Type a (MPS IIIA) Disease Diagnosed by the MPS Brazil Network.

Acute transient psychotic episode as presenting sign of Mucopolysaccharidosis III A (Sanfilippo Syndrome type A) in an adolescent patient.

Acute transient psychotic episode as presenting sign of Mucopolysaccharidosis III A (Sanfilippo Syndrome type A) in an adolescent patient.

Human induced pluripotent stem cell line (PNUSCRi006-A) derived from a patient with Sanfilippo syndrome type A exhibiting a mutation in SGSH gene.

Human induced pluripotent stem cell line (PNUSCRi006-A) derived from a patient with Sanfilippo syndrome type A exhibiting a mutation in SGSH gene.

Mucopolysaccharidoses types I and IIIA: Diagnosis and identification of novel polymorphisms associated with common mutations in Moroccan patients.

Mucopolysaccharidoses types I and IIIA: Diagnosis and identification of novel polymorphisms associated with common mutations in Moroccan patients.

Initiation of fluoxetine in a pediatric patient with Mucopolysaccharidosis IIIA: Early observations.

Initiation of fluoxetine in a pediatric patient with Mucopolysaccharidosis IIIA: Early observations.

Ability change across multiple domains in mucopolysaccharidosis (Sanfilippo syndrome) type IIIA.

Ability change across multiple domains in mucopolysaccharidosis (Sanfilippo syndrome) type IIIA.

Late-onset mucopolysaccharidosis type IIIA mimicking Usher syndrome.

Late-onset mucopolysaccharidosis type IIIA mimicking Usher syndrome.